Seneca Biopharma, Inc.

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 2.13%132.490.0%$3025.78m
BNGOBioNano Genomics, Inc. 23.74%8.600.0%$1456.10m
GILDGilead Sciences, Inc. 1.64%63.421.0%$662.01m
AMGNAmgen, Inc. 1.75%245.891.3%$595.98m
ALXNAlexion Pharmaceuticals, Inc. 0.24%157.032.0%$543.98m
CRSPCRISPR Therapeutics AG -1.10%207.730.6%$533.93m
NVAXNovavax, Inc. -0.84%128.8992.9%$491.09m
REGNRegeneron Pharmaceuticals, Inc. -0.34%516.132.7%$479.74m
ILMNIllumina, Inc. 2.36%379.813.5%$367.05m
BIIBBiogen, Inc. -1.02%277.431.7%$360.20m
VRTXVertex Pharmaceuticals, Inc. 0.18%226.521.9%$345.04m
BNTXBioNTech SE -2.41%103.300.0%$330.03m
SRPTSarepta Therapeutics, Inc. 2.77%92.3913.8%$291.46m
OCGNOcugen, Inc. 3.90%2.270.0%$281.27m
EDITEditas Medicine, Inc. 6.91%81.167.9%$262.03m

Company Profile

Seneca Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel & proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD.